Model Medicines, Inc. filed a Form D with the Securities and Exchange Commission on 2026-10-21.
Model Medicines, Inc. filed a Form D notice of an exempt securities offering with the SEC on October 21, 2026. The filing reports $5.12M sold. It names Daniel Haders (President) (SEC Form D, October 21, 2026).
Is this your company?
Sell to companies like Model Medicines, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2026-10-21 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Model Medicines, Inc.
Free to see. No signup.
Get an email when Model Medicines, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Model Medicines, Inc. raises, hires or launches. No email unless you switch it on.
Watch Model Medicines, Inc. →Get the full cited report on Model Medicines, Inc.
What the filing shows about Model Medicines, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Model Medicines, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Model Medicines, Inc.'s address as 5120 Shoreham Place, Suite 285, San Diego, CA 92122.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Model Medicines, Inc. is a registered filer with the SEC (CIK 1892786) and has filed since 2024-02-07. 4 filings are on record, the latest on 2026-10-21.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Model Medicines, Inc.'s Form D of 2026-10-21 names Daniel Haders as its officers, directors or promoters.
Its new offerings report $24.08M sold across 4 offerings, as its own filings state.
Each marker is one filing. The larger marker is the filing this page is about.
Trailing twelve months. 4172 filings in Other, totalled by week. The dot is this raise, $5.12M, on the same scale — one filing against the whole group's total, so it sits low by construction.
Checked away from the filing. What is below does not come from the record on sec.gov.
Model Medicines engineers first-in-class small molecules against biological choke points, using AI to advance pipeline-in-a-pill therapeutics across high-impact diseases.
The title and description the site itself served, answering 200. Not a cached copy and not the company's directory entry — what was live when we asked.
On the filing as: Executive Officer.
Daniel Haders is named as President on the Form D that Model Medicines, Inc. filed with the SEC on 21 October 2026, the only person that filing names.
1 person named on the filing — 1 holding an executive role.
Named as of the 2026-10-21 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
What the filing shows about Model Medicines, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Model Medicines, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Model Medicines, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Model Medicines, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Model Medicines, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov, and from the company's own site, read directly on 2026-10-22 (modelmedicines.com).
Each opens in a new tab, filled in for Model Medicines, Inc.. With no account yet, you sign up free and land on the result.
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/model-medicines-inc-form-d-000001